Dov A. Goldstein M.D., Director at Esperion Therapeutics, Inc. (ESPR), bought 2,054,594 shares at $14.00 ($3.3M) on 2013-07-01, disclosed to the SEC on 2013-07-01.
Open-market purchase of $3.3M ESPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,816,475 | $0 | 0.0% |
| 2 | $14.00 | 238,119 | $3.3M | 100.0% |
| Total | $1.62 avg | 2,054,594 | $3.3M | 100% |
| Filing → |
| NBSE | BUY | 2021-04-27 | $60K | — | Filing → |
| NBSE | BUY | 2020-05-04 | $60K | — | Filing → |
| ESPR | SELL | 2017-03-23 | $66.7M | — | Filing → |